Delivery Order SPE2DB24D2010-SPE2DB25FAACZ
Award Date
7/1/25
Potential Completion Date
7/23/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 100 unit vials, with a ceiling value of $1,722.72 and a period of performance through July 24, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of BOTOX with a ceiling value of $8,613.60. The contract is a Firm Fixed Price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 unit vials of BOTOX, a prescription medication, with a ceiling value of $15,056.25. The contract is a firm fixed-price delivery order with a performance period extending through June 26, 2025. This award is associated with Amerisourcebergen Drug Corp's larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of the medication BOTOX, with a ceiling value of $4,306.80 and a completion date of June 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 unit vials of BOTOX, a medication used for various medical purposes. The contract has a firm fixed price of $12,821.85 and a completion date of July 23, 2025. This contract is not set-aside and is awarded as part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of BOTOX, a medication used for various medical and cosmetic purposes. The contract has a ceiling value of $12,821.85 and a completion date of July 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a specialty medication, with a ceiling value of $1,204.50 and a completion date of December 27, 2024. The contract is a firm-fixed-price, delivery order contract type and was not set aside for a specific business category. AmerisourceBergen Drug Corp...
This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 100-unit vials of the medication Botox, with a ceiling value of $1,722.72 and a performance period through July 3, 2025. The contract is designated as a Firm Fixed Price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 200-unit vials of BOTOX, a medication used for various medical and cosmetic applications. The contract has a ceiling value of $10,257.48 and is a firm fixed-price delivery order. The award does not have a set-aside designation, indicating open competition. The contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit BOTOX vials, with a ceiling value of $1,709.60 and a performance period through July 2, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...